Correction

Abstract In the paper by Laudon et al. published in J. Endocr. (1988) 116, 43–53 the nomenclature of the melatonin antagonist should be N-(2,4-dinitrophenyl)-5-methoxytryptamine instead of N-(3,5-dinitrophenyl)-5-methoxytryptamine, and the starting material should be fluoro-2,4-dinitrobenzene instea... View More